Range
40.74 - 41.91
Vol / Avg.
321.3K/560.9K
Div / Yield
-
52 Wk
39.77 - 98.39
Mkt Cap
2.4B
Payout Ratio
-
Open
41.35
P/E
3.18
EPS
-1.83
Shares
58.8M
Outstanding
58.8M
Total Float
43.8M
load more
Sector: Health Care.Industry: Biotechnology
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-02
REV
Q2 2021Est.ActualSurprise
EPS-1.690-1.830 -0.1400
REV2.010M1.643M-367.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Sage Therapeutics Questions & Anwsers

Q

How do I buy Sage Therapeutics (SAGE) stock?

A

You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sage Therapeutics's (SAGE) competitors?

Q

What is the target price for Sage Therapeutics (SAGE) stock?

A

The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by Oppenheimer on October 20, 2021. The analyst firm set a price target for 84.00 expecting SAGE to rise to within 12 months (a possible 102.80% upside). 28 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Sage Therapeutics (SAGE)?

A

The stock price for Sage Therapeutics (NASDAQ: SAGE) is $41.42 last updated Fri Oct 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Sage Therapeutics (SAGE) pay a dividend?

A

There are no upcoming dividends for Sage Therapeutics.

Q

When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?

A

Sage Therapeutics’s $Q3 earnings are confirmed for after-market on $November 2, 2021.

Q

Is Sage Therapeutics (SAGE) going to split?

A

There is no upcoming split for Sage Therapeutics.

Q

What sector and industry does Sage Therapeutics (SAGE) operate in?

A

Sage Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.